IMTYTIM
LIVE

Serial Number

79295502

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IMTYTIM Trademark

Serial Number: 79295502 • Registration: 6367027

IMTYTIM is a trademark filed by NOVARTIS AG on August 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 18, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Cancellation Date

June 4, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 23, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jun 23, 2024 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 24, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 24, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2021 CNSA
REFUSAL PROCESSED BY IB
Jan 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2020 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Nov 30, 2020 RFWR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 2, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2020 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 28, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 27, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 23, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 21, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 8, 2020 REPR